Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Lupus can cause hair loss and nail changes, with treatments available for both.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The review says skin conditions with sterile pustules need more research for better treatments.